Home/Filings/4/0000914190-19-000424
4//SEC Filing

Spandow Oliver J. 4

Accession 0000914190-19-000424

CIK 0001196298other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 4:25 PM ET

Size

8.1 KB

Accession

0000914190-19-000424

Insider Transaction Report

Form 4
Period: 2019-11-25
Transactions
  • Purchase

    Common Stock

    2019-11-25$8.17/sh+1,000$8,17010,786 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $5.58Exp: 2028-08-10Common Stock (9,466 underlying)
    9,466
  • Stock Option (Right to Buy)

    Exercise: $5.85Exp: 2028-12-19Common Stock (5,161 underlying)
    5,161
Footnotes (3)
  • [F1]The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.079 to $8.50. The reporting person undertakes to provide Nephros, Inc., any security holder of Nephros, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The option vests as to 3,156 shares on 8/10/19 and as to 3,155 shares on each of 8/10/20 and 8/10/21.
  • [F3]The option vests as to 1,721 shares on 12/19/18 and as to 1,720 shares on each of 12/19/19 and 12/19/20.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001749836

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:25 PM ET
Size
8.1 KB